BioMarin Pharmaceutical Inc., based in San Rafael, just released its second-quarter earnings for 2025. The rare disease biopharma company posted profits that blew past Wall Street’s expectations, with revenue growth so strong they raised their full-year guidance.
But here’s the twist: even with these numbers, the company’s share price has dropped, and they’ve cut jobs at their Marin County sites. It’s a strange mix of wins and setbacks for one of North Bay’s biggest biotech players.
Discover hand-picked hotels and vacation homes tailored for every traveler. Skip booking fees and secure your dream stay today with real-time availability!
Browse Accommodations Now
BioMarin’s Q2 Financial Performance Exceeds Expectations
The San Rafael-based company reported a profit of $240.5 million for Q2 2025, or $1.23 per share. Adjusted earnings hit $1.44 per share, way over Wall Street’s $1.03 prediction.
Revenue reached $825.4 million, beating analyst forecasts of $766.2 million. That’s a pretty solid showing by any standard.
“These results show how resilient our business really is, and there’s still strong demand for our specialized treatments,” said a spokesperson at the Novato campus. Most of BioMarin’s research happens there.
BioMarin leads the pack in rare genetic disease treatments, which seems to pay off even when the broader Marin County economy feels shaky.
Revised Guidance Signals Confidence
After this quarter, BioMarin bumped up its full-year outlook. They now expect earnings between $4.40 and $4.55 per share, with revenue projected between $3.13 billion and $3.2 billion.
This move suggests they’re feeling good about growth, not just in San Rafael and Novato, but across all locations. Some industry analysts in Mill Valley and Sausalito point to strong product adoption and better operational efficiency as reasons for the guidance hike.
The company’s Marin County labs keep turning out treatments that fill a real need for patients with rare genetic disorders worldwide.
Share Price Challenges Despite Strong Fundamentals
Even with these financial wins, BioMarin’s stock hasn’t kept up. Shares traded at $60.21 after the announcement, which is a 28% slide over the last year.
Since the start of 2025, the stock’s down more than 8%. That’s left some investment advisors in Corte Madera and Tiburon scratching their heads, since the fundamentals look solid.
“This gap between performance and price likely says more about the whole biotech sector than BioMarin itself,” said a financial analyst at a Larkspur firm. “Investors in Marin County and elsewhere are watching to see how this plays out in the next few quarters.”
Recent Workforce Reductions
All this financial news lands during a tough stretch for BioMarin’s employees. The company recently laid off workers across its California operations, including at the San Rafael headquarters and Novato research sites.
Biotech layoffs aren’t unique to BioMarin—they’re happening across Marin County and the Bay Area. In towns like Fairfax, San Anselmo, and other nearby communities, these job cuts hit home, since a lot of BioMarin staff live there.
Business leaders in Greenbrae and Kentfield hope the company’s strong results might eventually mean new jobs. For now, though, people are waiting to see what comes next.
Looking Forward: BioMarin’s Place in Marin’s Economy
BioMarin stands out as one of the biggest employers in Marin County. Its ups and downs ripple through communities from Belvedere to Bolinas.
Even with stock market hiccups, the company’s financial results give locals a bit of confidence. People seem to feel there’s some stability in BioMarin sticking around.
Economic development folks in Ross and Stinson Beach seem pretty upbeat about BioMarin’s future. The company keeps its headquarters rooted in San Rafael and runs major operations in Novato.
Sure, they’ve made some workforce changes, but BioMarin’s ongoing profitability points to it staying a key player in Marin’s business scene. Hard to imagine the county without them, honestly.
Here is the source article for this story: BioMarin: Q2 Earnings Snapshot
Find available hotels and vacation homes instantly. No fees, best rates guaranteed!
Check Availability Now
